Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Weekly Wrap 16 September

Grady Wulff
September 16, 2022

Morning Bell 16 September

Sophia Mavridis
September 16, 2022

Morning Bell 15 September

Sophia Mavridis
September 15, 2022

Closing Bell 14 September

Grady Wulff
September 14, 2022

Morning Bell 14 September

Grady Wulff
September 14, 2022

Closing Bell 13 September

Grady Wulff
September 13, 2022

Morning Bell 13 September

Paulina Peters
September 13, 2022

Closing Bell 12 September

Grady Wulff
September 12, 2022

Morning Bell 12 September

Grady Wulff
September 12, 2022

Weekly Wrap 9 September

Grady Wulff
September 9, 2022

Morning Bell 9 September

Sophia Mavridis
September 9, 2022

Closing Bell 8 September

Grady Wulff
September 8, 2022